Based on the type of tumor and stage of your uterine (endometrial) cancer, we may recommend that you undergo chemotherapy to ensure cancer cells that might remain following surgery for endometrial cancer are eliminated, or to treat disease that has spread (metastasized).
We led the way in demonstrating the effectiveness of the targeted drug bevacizumab (Avastin) for endometrial cancer, which is now considered a standard treatment for recurrent forms of the disease.
Or we may recommend that you receive hormone therapy designed to prevent cancer cells from getting to or using the hormones they may need to grow. This treatment is done to stop the spread of certain types of advanced or recurrent uterine cancer. Our doctors are experienced in understanding which women will best benefit from hormone-blocking drugs.